These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 9758308

  • 1. Effect of blood glucose concentrations on the development of chronic complications of diabetes mellitus.
    Swidan SZ, Montgomery PA.
    Pharmacotherapy; 1998; 18(5):961-72. PubMed ID: 9758308
    [Abstract] [Full Text] [Related]

  • 2. The association between intensive glycemic control and vascular complications in type 2 diabetes mellitus: a meta-analysis.
    Ma J, Yang W, Fang N, Zhu W, Wei M.
    Nutr Metab Cardiovasc Dis; 2009 Nov; 19(9):596-603. PubMed ID: 19819121
    [Abstract] [Full Text] [Related]

  • 3. Defining the role of incretin mimetic therapy in the management of type 2 diabetes.
    Unger J, Nadeau DA.
    J Fam Pract; 2007 Dec; 56(12 Suppl New):S4-S10. PubMed ID: 18664341
    [Abstract] [Full Text] [Related]

  • 4. Effects of oral antihyperglycemic agents in modifying macrovascular risk factors in type 2 diabetes.
    Lebovitz HE.
    Diabetes Care; 1999 Apr; 22 Suppl 3():C41-4. PubMed ID: 10189561
    [Abstract] [Full Text] [Related]

  • 5. Type 2 diabetes mellitus: prevention of macrovascular complications.
    Meeuwisse-Pasterkamp SH, van der Klauw MM, Wolffenbuttel BH.
    Expert Rev Cardiovasc Ther; 2008 Mar; 6(3):323-41. PubMed ID: 18327994
    [Abstract] [Full Text] [Related]

  • 6. [Blood pressure control in patients with diabetes mellitus. Focus on postprandial blood glucose values and cardiovascular risk].
    MMW Fortschr Med; 2012 Feb 23; 154(3):82-3. PubMed ID: 22458177
    [No Abstract] [Full Text] [Related]

  • 7. [Postprandial hyperglycemia. Cardiovascular risks and new therapeutic strategies].
    Sjöholm A.
    Lakartidningen; 2001 Feb 28; 98(9):937-40. PubMed ID: 11292972
    [Abstract] [Full Text] [Related]

  • 8. Natural history of cardiovascular disease in patients with diabetes: role of hyperglycemia.
    Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M.
    Diabetes Care; 2008 Feb 28; 31 Suppl 2():S155-60. PubMed ID: 18227478
    [Abstract] [Full Text] [Related]

  • 9. Implications of the diabetes control and complications trial. American Diabetes Association.
    J Fla Med Assoc; 1998 Aug 28; 85(2):22-4. PubMed ID: 9782715
    [No Abstract] [Full Text] [Related]

  • 10. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
    Weiss IA, Valiquette G, Schwarcz MD.
    Cardiol Rev; 2009 Aug 28; 17(4):165-75. PubMed ID: 19525678
    [Abstract] [Full Text] [Related]

  • 11. Epidemiological studies on the effects of hyperglycemia and improvement of glycemic control on macrovascular events in type 2 diabetes.
    Haffner SM.
    Diabetes Care; 1999 Apr 28; 22 Suppl 3():C54-6. PubMed ID: 10189563
    [Abstract] [Full Text] [Related]

  • 12. Effect of insulin therapy on macrovascular risk factors in type 2 diabetes.
    Boyne MS, Saudek CD.
    Diabetes Care; 1999 Apr 28; 22 Suppl 3():C45-53. PubMed ID: 10189562
    [Abstract] [Full Text] [Related]

  • 13. Glycemic targets for patients with type 2 diabetes mellitus.
    Hamnvik OP, McMahon GT.
    Mt Sinai J Med; 2009 Jun 28; 76(3):227-33. PubMed ID: 19421966
    [Abstract] [Full Text] [Related]

  • 14. Insulin-associated weight gain in diabetes--causes, effects and coping strategies.
    Russell-Jones D, Khan R.
    Diabetes Obes Metab; 2007 Nov 28; 9(6):799-812. PubMed ID: 17924864
    [Abstract] [Full Text] [Related]

  • 15. [Epidemiology of cardio-vascular complications of diabetes].
    Grimaldi A, Heurtier A.
    Diabetes Metab; 1999 Jun 28; 25 Suppl 3():12-20. PubMed ID: 10421988
    [Abstract] [Full Text] [Related]

  • 16. Effect of intensive glycemic control on levels of markers of inflammation in type 1 diabetes mellitus in the diabetes control and complications trial.
    Schaumberg DA, Glynn RJ, Jenkins AJ, Lyons TJ, Rifai N, Manson JE, Ridker PM, Nathan DM.
    Circulation; 2005 May 17; 111(19):2446-53. PubMed ID: 15867184
    [Abstract] [Full Text] [Related]

  • 17. Prevention of macrovascular disease in patients with diabetes mellitus: opportunities for intervention.
    Mazzone T.
    Am J Med; 2007 Sep 17; 120(9 Suppl 2):S26-32. PubMed ID: 17826043
    [Abstract] [Full Text] [Related]

  • 18. Type 2 diabetes treatment and macrovascular complications--fat and sugar make a dangerous soufflé.
    Bajaj M, Jialal I.
    Metab Syndr Relat Disord; 2009 Apr 17; 7(2):79-81. PubMed ID: 19351292
    [No Abstract] [Full Text] [Related]

  • 19. [Hypoglycemic treatment of type 2 diabetes].
    Thorsby P, Kilhovd B, Sletmo R, Martinsen S, Birkeland KI.
    Tidsskr Nor Laegeforen; 2000 Aug 30; 120(20):2434-40. PubMed ID: 11475233
    [Abstract] [Full Text] [Related]

  • 20. Hypoglycemia in insulin-treated diabetes: a case for increased vigilance.
    Unger J, Parkin C.
    Postgrad Med; 2011 Jul 30; 123(4):81-91. PubMed ID: 21680992
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.